1378TiPA phase I clinical trial investigating the therapeutic cancer vaccine UV1 in combination with pembrolizumab as first-line treatment of patients with malignant melanoma
Agarwala, S S, O’Day, S J, Zakharia, Y, Voorhies, B, Milhem, MVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz255.066
Date:
October, 2019
Fichier:
PDF, 79 KB
2019
File converter
Plus de résultats de recherche
More benefits 
